Showing 1 - 20 results of 31 for search 'Ho, W.', query time: 0.04s
Refine Results
-
1
-
2
Looking for Dante: exploring the 'Divine Comedy' in print from the 15th century to today by Ho, W-G, Bowen, R, Gilson, S
Published 2024Book -
3
-
4
-
5
-
6
-
7
-
8
Polygenic risk scores for prediction of breast cancer risk in Asian populations by Ho, W-K, Tai, M-C, Dennis, J, Millwood, IY, Lin, K, Walters, RG, Et al.
Published 2021Journal article -
9
-
10
Prevalence and Characterization of Multidrug-Resistant and Extended-Spectrum Beta-Lactamase-Producing Escherichia coli from Pediatric Wards of a Malaysian Hospital by Ho, W.S., Balan, G., Puthucheary, S., Kong, B.H., Lim, K.T., Tan, L.K., Koh, X.P., Yeo, C.C., Thong, Kwai Lin
Published 2012
Article -
11
-
12
-
13
Flavokawain B induced cytotoxicity in two breast cancer cell lines, MCF-7 and MDA-MB231 and inhibited the metastatic potential of MDA-MB231 via the regulation of several tyrosine k... by Abu, N., Akhtar, M.N., Yeap, S.K., Lim, K.L., Ho, W.Y., Abdullah, M.P., Ho, C.L., Omar, A.R., Ismail, J., Alitheen, N.B.
Published 2016
Article -
14
Induction of apoptosis and regulation ofMicroRNA expression by (2E,6E)-2,6-bis-(4-hydroxy-3-methoxybenzylidene)- cyclohexanone (BHMC) treatment on MCF-7 breast cancer cells by Yeap, S. K., Ali, N. M., Akhtar, M. N., Razak, N. A., Chong, Z. X., Ho, W. Y., Boo, L., Zareen, S., Kurniawan, T. A., Avtar, R., Ng, S. Y. L., Ong, A. H. K.
Published 2021
Article -
15
-
16
Phenotypic and microRNA transcriptomic profiling of the MDA-MB-231 spheroid-enriched CSCs with comparison of MCF-7 microRNA profiling dataset by Boo, L., Ho, W.Y., Ali, N.M., Yeap, S.K., Ky, H., Chan, Kok Gan, Yin, W.F., Satharasinghe, D.A., Liew, W.C., Tan, S.W., Cheong, S.K., Ong, H.K.A.
Published 2017Article -
17
AML-464 Tolerability and efficacy of the first-in-class anti-CD47 antibody magrolimab combined with azacitidine in frontline patients with TP53-mutated acute myeloid leukemia (AML)... by Daver, N, Vyas, P, Kambhampati, S, Malki, MA, Larson, R, Asch, A, Mannis, G, Chai-Ho, W, Tanaka, T, Bradley, T, Jeyakumar, D, Wang, E, Xing, G, Chao, M, Ramsingh, G, Renard, C, Lal, I, Zeidner, J, Sallman, D
Published 2022Conference item -
18
Tolerability and efficacy of the first-in-class anti-CD47 antibody magrolimab combined with azacitidine in frontline TP53m AML patients: Phase 1b results by Daver, NG, Vyas, P, Kambhampati, S, Al Malki, MM, Larson, RA, Asch, AS, Mannis, GN, Chai-Ho, W, Tanaka, TN, Bradley, TJ, Jeyakumar, D, Wang, ES, Xing, G, Chao, M, Ramsingh, G, Renard, C, Lal, I, Zeidner, JF, Sallman, DA
Published 2022Journal article -
19
Tolerability and efficacy of the anticluster of differentiation 47 antibody magrolimab combined with azacitidine in patients with previously untreated AML: phase ib results by Daver, NG, Vyas, P, Kambhampati, S, Al Malki, MM, Larson, RA, Asch, AS, Mannis, G, Chai-Ho, W, Tanaka, TN, Bradley, TJ, Jeyakumar, D, Wang, ES, Sweet, K, Kantarjian, HM, Garcia-Manero, G, Komrokji, R, Xing, G, Ramsingh, G, Renard, C, Zeidner, JF, Sallman, DA
Published 2023Journal article -
20
Outcome for post-transplant melanoma: a multicentre European study by Matin, R, Proby, C, McGregor, J, Bouwes-Bavinck, J, del Marmol, V, Euvrard, S, Ferrandiz, C, Geusau, A, Ho, W, Hofbauer, G, Imko, B, Lally, A, Lear, J, Lebbe, C, Murphy, G, Seckin, D, Stockfleth, E, Ulrich, C, Wojnarowska, F, Harwood, C
Published 2007Conference item